Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial

Peer Review reports

Original Submission
19 Mar 2021	Submitted	Original manuscript
25 Mar 2021	Author responded	Author comments - Patricia Jannet Garcia
22 Mar 2021	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
25 Mar 2021	Submitted	Manuscript version 2
Publishing
29 Mar 2021	Editorially accepted
9 Apr 2021	Article published	10.1186/s13063-021-05236-2

Back to article page